Hims & Hers Health, Inc. (HIMS) — Analyst outlook / Analyst consensus target is. Based on 19 analyst ratings, the consensus is bullish — 6 Buy, 13 Hold.
The consensus price target is $29.92 (low: $12.50, high: $60.00), representing an upside of 40.1% from the current price $21.36.
Analysts estimate Earnings Per Share (EPS) of $0.54 and revenue of $1.47B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.58 vs est $0.54 (beat +7.5%). 2025: actual $0.57 vs est $0.46 (beat +22.8%). Analyst accuracy: 87%.
HIMS Stock — 12-Month Price Forecast
$29.92
▲ +40.07% Upside
Average Price Target
Based on 19 Wall Street analysts offering 12-month price targets for Hims & Hers Health, Inc., the average price target is $29.92, with a high forecast of $60.00, and a low forecast of $12.50.
The average price target represents a +40.07% change from the last price of $21.36.
Highest Price Target
$60.00
Average Price Target
$29.92
Lowest Price Target
$12.50
HIMS Analyst Ratings
Hold
Based on 19 analysts giving stock ratings to Hims & Hers Health, Inc. in the past 3 months
EPS Estimates — HIMS
87%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.58
vs Est $0.54
▲ 6.9% off
2025
Actual $0.57
vs Est $0.46
▲ 18.5% off
Profitability Outlook
Company is profitable but with thin earnings per share. EPS trend is declining.
Revenue Estimates — HIMS
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $1.477B
vs Est $1.467B
▲ 0.7% off
2025
Actual $2.348B
vs Est $2.349B
▼ 0.0% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
